DE1450454U - - Google Patents

Info

Publication number
DE1450454U
DE1450454U DENDAT1450454D DE1450454DU DE1450454U DE 1450454 U DE1450454 U DE 1450454U DE NDAT1450454 D DENDAT1450454 D DE NDAT1450454D DE 1450454D U DE1450454D U DE 1450454DU DE 1450454 U DE1450454 U DE 1450454U
Authority
DE
Germany
Prior art keywords
dte
dea
den
ç3tlete
xnspruoh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1450454D
Other languages
German (de)
English (en)
Publication of DE1450454U publication Critical patent/DE1450454U/de
Active legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DENDAT1450454D Active DE1450454U (enrdf_load_stackoverflow)

Publications (1)

Publication Number Publication Date
DE1450454U true DE1450454U (enrdf_load_stackoverflow)

Family

ID=758234

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1450454D Active DE1450454U (enrdf_load_stackoverflow)

Country Status (1)

Country Link
DE (1) DE1450454U (enrdf_load_stackoverflow)

Similar Documents

Publication Publication Date Title
DE1450454U (enrdf_load_stackoverflow)
Havlir et al. Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS
Kumana et al. Systemic availability of arsenic from oral arsenic-trioxide used to treat patients with hematological malignancies
Begley et al. Lenacapavir sustained delivery formulation supports 6-month dosing interval
SK423889A3 (en) Pharmaceutical mixture for the prevention of veneral diseases
Reynes et al. TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals
Lo et al. Fungal peritonitis-current status 1998
WO2021164891A1 (de) Modulare schutzbekleidungseinheit sowie deren verwendung
US20200348108A1 (en) Ballistic shield and method of using multiple interconnected ballistic shields to protect a group of individuals
Segal-Maurer et al. Potent antiviral activity of lenacapavir in phase 2/3 in heavily art-experienced PWH
Yilmaz et al. In vitro effects of ciprofloxacin, levofloxacin and moxifloxacin on Mycobacterium tuberculosis isolates
Clay et al. Enthalpies of formation and solution of macrocyclic and noncyclic tetraaza ligands. Origins of the enthalpy term in the macrocyclic effect
Lee et al. Hepatitis B virus reactivation after 23 months of rituximab-based chemotherapy in an HBsAg-negative, anti-HBs-positive patient with follicular lymphoma
Gaddoni et al. Contact dermatitis among decorators and enamellers in hand-made ceramic decorations.
Neufeld et al. Biochemical Findings in Normal and Trauma-Resistant Rats Following Trauma.
DE1517474U (enrdf_load_stackoverflow)
Murskyj Disseminated histoplasmosis after vedolizumab treatment for ulcerative colitis
Hoesley et al. Overview of oral azole drugs as systemic antifungal therapy
Woods et al. Methoclocinnamox: a μ partial agonist with pharmacotherapeutic potential for heroin abuse
DE1502554U (enrdf_load_stackoverflow)
ES2304163T3 (es) Solucion inyectable esteril estable, lista para usar, de 9-((1,3-dihidroxipropan-2-iloxi)metil)-2-amina-1h-purin-6(9h)-ona; sistema cerrado para envasar solucion; procedim. eliminar residuos alcalinos cristales de 9-((1,3-dihidroxipropan-2-iloxi)metil)-2-amina-1h-purin-6(9h)-ona.
CN211584289U (zh) 一种新型便于艾滋病人使用的药盒
Prugnard et al. Chemistry and structure-activity relationships of biguanides
CN215641145U (zh) 化学品物理危险性鉴定用远距检测装置
PRUGNARD et al. C. Structure-Activity Relationships